期刊文献+

脂蛋白(a)对急性ST段抬高型心肌梗死患者行经皮冠状动脉介入术后发生对比剂肾病的影响 被引量:8

Association between lipoprotein(a) and contrast-induced nephropathy in patients with acute ST-segment elevation myocardial infarction and undergoing primary percutaneous coronary intervention
原文传递
导出
摘要 目的探讨不同血清脂蛋白(a)[Lp(a)]水平患者在急性ST段抬高型心肌梗死(STEMI)行经皮冠状动脉介入术(PCI)后发生对比剂肾病(CIN)的差异。方法连续入选潍坊市人民医院2015年11月至2017年10月因STEMI而行PCI的患者745例。根据术后是否发生CIN,分为CIN组(73例)和非CIN组(672例)。分析两组患者临床基线资料的差异。采用多因素Logistic回归分析血清Lp(a)水平与STEMI患者PCI后发生CIN的相关性。结果 CIN组Lp(a)水平高于非CIN组[(317.8±123.7)比(173.1±76.2)mg/L,P<0.01]。多因素Logistic回归分析显示,在校正年龄、糖尿病、估算的肾小球滤过率、同型半胱氨酸等因素后,Lp(a)水平升高是STEMI患者PCI后发生CIN的独立危险因素(OR=1.199,95%CI 1.150~1.251,P<0.01)。结论血清Lp(a)水平升高STEMI患者行PCI后易发生CIN。 Objective To explore the association between the level of serum lipoprotein(a)[Lp(a)]and the incidence of contrast-induced nephropathy(CIN)in patients with acute ST-segment elevation myocardial infarction(STEMI)and undergoing primary percutaneous coronary intervention(PCI).Methods From November 2015 to October 2017,745 STEMI patients who underwent primary PCI in WeiFang People’s Hospital were recruited consecutively.Patients were divided into CIN group(n=73)and non-CIN group(n=672).The baseline clinical data were compared between the two groups.Multivariable logistic regression analysis was performed to identify the independent risk factors for CIN.Results The level of serum Lp(a)in STEMI patients was significantly higher in patients developed CIN than in those did not((317.8±123.7)vs(173.1±76.2)mg/L,P<0.01)After adjusted for age,diabetes,creatinine clearance and homocysteine etc,multivariate Logistic regression analysis showed that an elevated Lp(a)level was an independent risk factor for CIN in STEMI patients after PCI(OR=1.199,95%CI 1.150-1.251,P<0.01).Conclusion Elevated serum Lp(a)level may be an independent risk factor for the occurrence of CIN in patients with STEMI after PCI.
作者 孙西锋 倪广臻 潘祥坡 魏成军 李世荣 孙肖伟 SUN Xi-feng;NI Guang-zhen;PAN Xiang-po;WEI Cheng-jun;LI Shi-rong;SUN Xiao-wei(Laboratory Department of WeiFang People’s Hospital,Weifang Shandong 261041,China;不详)
出处 《中华高血压杂志》 CAS CSCD 北大核心 2019年第3期262-266,共5页 Chinese Journal of Hypertension
关键词 造影剂 肾病 脂蛋白(a) contrast media nephrosis lipoprotein(a)
  • 相关文献

参考文献3

二级参考文献37

共引文献39

同被引文献69

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部